Award Year / Program / Phase:2010 / SBIR / Phase I
Agency:HHS
Principal Investigator:Joel D. Quispe
Award Amount:$193,829.00
Abstract:
DESCRIPTION (provided by applicant): Characterization of nanoparticles and biologics is a critical step in the development of important new pharmaceutical therapeutics as, in many cases, preclinical characterization is the rate-limiting phase of the commer
cialization process. Nanoparticle… More
DESCRIPTION (provided by applicant): Aggregation in antibody therapeutics is a topic of increasing concern in the biopharmaceutical industry, as these aggregates are believed to play an undesirable role resulting in adverse health effects to patients by inducing immunogenicity, altering therapeutic… More